The new article elaborates further on the submission of use-related risk analyses, and also provides certain examples intended to demonstrate the way the regulatory approach described in the guidance should be applied.
The article highlights the key points regarding the approach to be followed in order to ensure healthcare professionals and patients are provided with accurate, factually correct, and up-to-date information about healthcare products.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.